XML 30 R24.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
9 Months Ended
Dec. 31, 2024
Class Of Stock [Line Items]  
Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity from March 31, 2024 to December 31, 2024:

 

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise Price

 

 

Aggregate
Intrinsic
Value

 

Outstanding at March 31, 2024

 

 

698,007

 

 

$

4.26

 

 

$

 

Options granted

 

 

1,154,172

 

 

$

0.59

 

 

$

 

Options cancelled / forfeited

 

 

(76,404

)

 

$

1.82

 

 

$

 

Options expired

 

 

(6,072

)

 

$

5.14

 

 

$

 

Outstanding at December 31, 2024

 

 

1,769,703

 

 

$

1.97

 

 

$

 

Vested and Exercisable at December 31, 2024

 

 

511,668

 

 

$

4.91

 

 

$

 

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following at December 31, 2024:

 

Common stock issuable pursuant to options outstanding and reserved under the 2012 Plan

 

 

415,553

 

Common stock reserved under the 2012 Plan

 

 

 

Common stock issuable pursuant to options outstanding and reserved under the A&R 2022 Plan

 

 

1,304,150

 

Common stock reserved under the A&R 2022 Plan

 

 

517,701

 

Common stock reserved under the 2023 ESPP

 

 

44,500

 

Common stock reserved under the 2021 Inducement Equity Plan

 

 

1,000

 

Common stock issuable pursuant to restricted stock units outstanding under the 2012 Plan

 

 

1,250

 

Common stock issuable pursuant to restricted stock units outstanding under the A&R 2022 Plan

 

 

117,642

 

Common stock issuable pursuant to options outstanding and reserved under the Inducement Plan

 

 

50,000

 

Common stock issuable pursuant to outstanding pre-funded warrants

 

 

1,034,000

 

Common stock issuable pursuant to outstanding common warrants

 

 

6,562,500

 

Total at December 31, 2024

 

 

10,048,296

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for all stock-based awards consists of the following (in thousands):

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

December 31, 2024

 

 

December 31, 2023

 

 

December 31, 2024

 

 

December 31, 2023

 

Research and development

 

$

19

 

 

$

40

 

 

$

70

 

 

$

87

 

General and administrative

 

 

111

 

 

 

117

 

 

 

371

 

 

 

1,220

 

Total

 

$

130

 

 

$

157

 

 

$

441

 

 

$

1,307

 

Fair Value of Employee Stock Options The fair value of stock options was estimated at the grant date using the following weighted average assumptions:

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

December 31, 2024

 

 

December 31, 2023

 

 

December 31, 2024

 

 

December 31, 2023

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

100.83

%

 

 

100.31

%

 

 

99.38

%

 

 

98.93

%

Risk-free interest rate

 

 

4.32

%

 

 

4.66

%

 

 

3.75

%

 

 

4.12

%

Expected life of options

 

6 years

 

 

6 years

 

 

6 years

 

 

6 years

 

Weighted average grant
   date fair value

 

$

0.32

 

 

$

1.16

 

 

$

0.47

 

 

$

1.38

 

 

Summary of Warrant Activity

The following table summarizes the Company’s Common Warrant activity from March 31, 2024 to December 31, 2024:

 

 

Number of
Warrants

 

 

Exercise
Price

 

Outstanding at March 31, 2024

 

 

 

 

$

 

Issued

 

 

6,562,500

 

 

$

0.80

 

Exercised

 

 

 

 

$

0.80

 

Outstanding at December 31, 2024

 

 

6,562,500

 

 

$

0.80

 

 

The following table summarizes the Company’s Pre-Funded Warrants activity from March 31, 2024 to December 31, 2024:

 

 

 

Number of
Warrants

 

 

Exercise
Price

 

Outstanding at March 31, 2024

 

 

 

 

$

 

Issued

 

 

5,000,000

 

 

$

0.001

 

Exercised

 

 

(3,966,000

)

 

$

0.001

 

Outstanding at December 31, 2024

 

 

1,034,000

 

 

$

0.001

 

Restricted stock units (RSUs) [Member]  
Class Of Stock [Line Items]  
Summary of Company's RSUs Activity The following table summarizes the Company’s RSUs activity for the nine months ended December 31, 2024:

 

 

 

Number of
Shares

 

 

Weighted
Average Price

 

Unvested at March 31, 2024

 

 

122,642

 

 

$

1.75

 

Granted

 

 

117,642

 

 

$

0.55

 

Vested

 

 

(121,392

)

 

$

1.66

 

Cancelled / forfeited

 

 

 

 

$

 

Unvested at December 31, 2024

 

 

118,892

 

 

$

0.65

 

ESPP Shares [Member]  
Class Of Stock [Line Items]  
Fair Value of Employee Stock Options The fair value of ESPP shares was estimated at the purchase period commencement date using the following assumptions:

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

 

December 31, 2024*

 

 

December 31, 2023*

 

 

December 31, 2024

 

 

December 31, 2023*

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

0.00

%

 

 

0.00

%

 

 

95.20

%

 

 

0.00

%

Risk-free interest rate

 

 

0.00

%

 

 

0.00

%

 

 

5.27

%

 

 

0.00

%

Expected term

 

 

 

 

 

 

 

6 months

 

 

 

 

Grant date fair value

 

$

 

 

$

 

 

$

0.39

 

 

$

 

*There were no participants in the ESPP for the purchase periods that commenced on March 1, 2023, September 1, 2023, or September 1, 2024.